GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hi-Clearance Inc (ROCO:1788) » Definitions » Cyclically Adjusted PS Ratio

Hi-Clearance (ROCO:1788) Cyclically Adjusted PS Ratio : 1.36 (As of May. 29, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Hi-Clearance Cyclically Adjusted PS Ratio?

As of today (2025-05-29), Hi-Clearance's current share price is NT$143.50. Hi-Clearance's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was NT$105.89. Hi-Clearance's Cyclically Adjusted PS Ratio for today is 1.36.

The historical rank and industry rank for Hi-Clearance's Cyclically Adjusted PS Ratio or its related term are showing as below:

ROCO:1788' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.18   Med: 1.38   Max: 1.83
Current: 1.36

During the past years, Hi-Clearance's highest Cyclically Adjusted PS Ratio was 1.83. The lowest was 1.18. And the median was 1.38.

ROCO:1788's Cyclically Adjusted PS Ratio is ranked better than
63.96% of 480 companies
in the Medical Devices & Instruments industry
Industry Median: 2.23 vs ROCO:1788: 1.36

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Hi-Clearance's adjusted revenue per share data for the three months ended in Mar. 2025 was NT$23.582. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is NT$105.89 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hi-Clearance Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Hi-Clearance's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hi-Clearance Cyclically Adjusted PS Ratio Chart

Hi-Clearance Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.42 1.60 1.43 1.32 1.33

Hi-Clearance Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.34 1.32 1.32 1.33 1.34

Competitive Comparison of Hi-Clearance's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Hi-Clearance's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hi-Clearance's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hi-Clearance's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Hi-Clearance's Cyclically Adjusted PS Ratio falls into.


;
;

Hi-Clearance Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Hi-Clearance's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=143.50/105.89
=1.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hi-Clearance's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Hi-Clearance's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=23.582/134.9266*134.9266
=23.582

Current CPI (Mar. 2025) = 134.9266.

Hi-Clearance Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 19.380 100.684 25.971
201509 19.041 100.392 25.591
201512 20.977 99.792 28.362
201603 19.274 100.470 25.884
201606 20.019 101.688 26.563
201609 20.031 101.861 26.533
201612 20.321 101.863 26.917
201703 19.957 102.862 26.178
201706 21.022 103.349 27.445
201709 21.309 104.136 27.610
201712 21.002 104.011 27.244
201803 21.691 105.290 27.797
201806 21.707 106.317 27.548
201809 21.640 106.507 27.414
201812 22.391 105.998 28.502
201903 22.783 107.251 28.662
201906 21.745 108.070 27.149
201909 20.566 108.329 25.615
201912 19.876 108.420 24.735
202003 20.297 108.902 25.148
202006 22.032 108.767 27.331
202009 21.891 109.815 26.897
202012 21.010 109.897 25.795
202103 21.565 111.754 26.036
202106 24.724 114.631 29.101
202109 22.161 115.734 25.836
202112 22.014 117.630 25.251
202203 24.205 121.301 26.924
202206 43.443 125.017 46.887
202209 24.452 125.227 26.346
202212 23.315 125.222 25.122
202303 23.995 127.348 25.423
202306 21.565 128.729 22.603
202309 22.085 129.860 22.947
202312 22.025 129.419 22.962
202403 21.659 131.776 22.177
202406 24.648 132.554 25.089
202409 22.652 133.029 22.975
202412 22.479 133.157 22.778
202503 23.582 134.927 23.582

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hi-Clearance  (ROCO:1788) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Hi-Clearance Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Hi-Clearance's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hi-Clearance Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Chongzhong Road, Lane 609, 8th Floor, Section 5, Taipei, TWN
Hi-Clearance Inc manufactures medical devices. It is engaged in the biochemical reagents and western medicine trading business. Its products are dialyzers, dialysis machines, RO machines, cardiac, radiation, and implant surgery devices, dental consumables implant material and equipment, and blood glucose monitor and nutrition products.

Hi-Clearance Headlines

No Headlines